QLGN - Qualigen Therapeutics GAAP EPS of -$4.85 misses by $3.60 revenue of $5M beats by $3.43M May, 02 2023 05:14 PM Qualigen Therapeutics Inc. 2023-05-02 17:14:48 ET Qualigen Therapeutics press release ( NASDAQ: QLGN ): Q4 GAAP EPS of -$4.85 misses by $3.60 . Revenue of $5M (-12.3% Y/Y) beats by $3.43M . For further details see: Qualigen Therapeutics GAAP EPS of -$4.85 misses by $3.60, revenue of $5M beats by $3.43M